The application deadline to serve on the committee is Dec. 11.
The FDA announced in October the creation of a digital health advisory committee which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
“Technology moves at an incredible pace, and we’re excited to have a committee of experts throughout the field who can help ensure our regulation of these exciting tools maintains an appropriate pace while working within parameters of safety and effectiveness standards,” Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence said in a news release.
The committee is expected to be fully operational in 2024. It will consist of nine voting members, including the chair. The agency seeks individuals with diverse scientific and technical experience.
The FDA is accepting applications until Dec. 11. The application can be found on the FDA Advisory Committee Membership Nomination Portal.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More